DrugPatentWatch Database Preview

LEVO-T Drug Profile

Email this page to a colleague

« Back to Dashboard

When do Levo-t patents expire, and what generic alternatives are available?

Levo-t is a drug marketed by Cediprof Inc and is included in one NDA. There is one patent protecting this drug.

This drug has eight patent family members in seven countries.

The generic ingredient in LEVO-T is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Levo-t

A generic version of LEVO-T was approved as levothyroxine sodium by MYLAN on June 5^th, 2002.

Summary for LEVO-T

International Patents:	8
US Patents:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	17
Bulk Api Vendors:	53
Patent Applications:	1,601
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for LEVO-T
DailyMed Link:	LEVO-T at DailyMed

See drug prices for LEVO-T

Pharmacology for LEVO-T

Drug Class

l-Thyroxine

Synonyms for LEVO-T

(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic aci d, sodium salt

(S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionic Acid Sodium Salt

054I36CPMN

1491-91-4

25416-65-3

3,3',5,5'-Tetraiodo-L-thyronine, sodium salt

50809-32-0

55-03-8

6260AF

A830452

AC-10210

AC-919

AK-46618

AKOS015918420

AKOS024284731

API0007805

BBC/815

Berlthyrox

C08212

C15H10I4NO4.Na

CHEBI:6446

CT-452

CTK4J3191

D-3,5-Diiodo-4-(3',5'-Diiodo-4'-hydroxyphenoxy)-phenylalanine sodium salt

D11113

Dathroid

DTXSID90883228

EBD2201200

Eferox

EINECS 200-221-4

eltroxin

Epitope ID:136776

Euthyrox

FT-0628030

FT-0658959

J-524276

KS-00000F9R

l-Thyroxine monosodium salt

L-Thyroxine sodium

L-Thyroxine sodium salt

L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt

L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, hydrate (9CI)

L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodiumsalt

L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt (1:1)

Laevoxin

Letter

Levaxin

Leventa

Levolet

Levoroxine

levothroid

Levothyrox

Levothyroxin-natrium

Levothyroxine sodique

Levothyroxine sodique [INN-French]

Levothyroxine sodium

Levothyroxine Sodium (anhydrous)

Levothyroxine sodium (INN)

Levothyroxine Sodium [USAN:INN]

Levothyroxine Sodium [USAN]

Levothyroxine sodium anhydrous

Levothyroxine sodium tablets

Levothyroxinum natricum

Levothyroxinum natricum [INN-Latin]

levotiroxina de sodio

Levotiroxina sodica

Levotiroxina sodica [INN-Spanish]

Levoxyl

LS-153817

LS-153822

Monosodium L-thyroxine

Novothyrox

NSC 259940

Oroxine

Q27107208

Ro-thyroxine

Roxstan

SCHEMBL34102

SODIUM (2S)-2-AMINO-3-[4-(4-HYDROXY-3,5-DIIODO-PHENOXY)-3,5-DIIODO-PHENYL]PROPANOATE

sodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate

sodium (2S)-2-azanyl-3-[4-[3,5-bis(iodanyl)-4-oxidanyl-phenoxy]-3,5-bis(iodanyl)phenyl]propanoate

Sodium (S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionate

sodium 4-o-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine

Sodium l-thyroxin

Sodium L-thyroxine

Sodium levothyroxine

Sodium thyroxin

Sodium thyroxinate

Sodium thyroxine

Sodium-L-thyroxine

Soloxine

ST078859

synthroid

Synthroid sodium

Tetroid

Thevier

Thyradin

Thyradin S

Thyro-Tabs

THYROID

Thyronamin

Thyrosit

Thyroxevan

Thyroxin sodium

Thyroxine sodique

Thyroxine sodium

Thyroxine sodium salt

Thyroxine, monosodium salt, L-

Thyroxinique

Thyroxinum natricum

Tiroidina

Tirosint

Tirosint-Sol

Tyrosint

UNII-054I36CPMN

Unithroid

YDTFRJLNMPSCFM-YDALLXLXSA-M

Z2798529463

US Patents and Regulatory Information for LEVO-T

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-001	Mar 1, 2002	AB1,AB2,AB3	RX	No	No
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-007	Mar 1, 2002	AB1,AB2,AB3	RX	No	No
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-004	Mar 1, 2002	AB1,AB2,AB3	RX	No	No
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-011	Mar 1, 2002	AB1,AB2,AB3	RX	No	No
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-012	Dec 8, 2003	AB1,AB2,AB3	RX	No	No
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-002	Mar 1, 2002	AB1,AB2,AB3	RX	No	No
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-003	Mar 1, 2002	AB1,AB2,AB3	RX	No	No

Expired US Patents for LEVO-T

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-009	Mar 1, 2002
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-001	Mar 1, 2002
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-005	Mar 1, 2002
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-011	Mar 1, 2002
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-008	Mar 1, 2002
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-006	Mar 1, 2002
Cediprof Inc	LEVO-T	levothyroxine sodium	TABLET;ORAL	021342-007	Mar 1, 2002

International Patents for LEVO-T

Country	Patent Number	Estimated Expiration
Canada	2404369
Australia	5295301
Japan	2003528931
European Patent Office	1267999
Australia	2001252953
World Intellectual Property Organization (WIPO)	0174448
Israel	152024